InduPro
Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease
$77MSeries B
Role not disclosedEC
Emerson Collective
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $86.3M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionUltralight
Develops AI-native operating system for preventive and personalized care
$9.3MSeed
Role not disclosed